NASDAQ: CBUSCibus Inc Stock
$2.15-0.20 (-8.51%)
Updated May 9, 2025
CBUS Price
$2.15
Fair Value Price
-$2.24
Market Cap
$73.68M
52 Week Low
$1.40
52 Week High
$19.56
P/E
-0.2x
P/B
0.8x
P/S
15.15x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.26M
Earnings
-$251.39M
Gross Margin
100%
Operating Margin
-5,095.47%
Profit Margin
-5,898.4%
Debt to Equity
2.74
Operating Cash Flow
-$58M
Beta
1.33
Next Earnings
May 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CBUS Overview
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CBUS's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Biotech
Industry Rating
F
CBUS
Ranked#416 of 458
Ranked#416 of 458
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $1.72 | A | |
| $44.23 | A | |
| $8.00 | A |
Be the first to know about important CBUS news, forecast changes, insider trades & much more!
CBUS News
Overview
Due Diligence Score
–
Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CBUS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CBUS ($2.15) is overvalued by 195.8% relative to our estimate of its Fair Value price of -$2.24 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CBUS ($2.15) is not significantly undervalued (195.8%) relative to our estimate of its Fair Value price of -$2.24 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CBUS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CBUS due diligence checks available for Premium users.
Valuation
CBUS fair value
Fair Value of CBUS stock based on Discounted Cash Flow (DCF)
Price
$2.15
Fair Value
-$2.24
Undervalued by
196.03%
CBUS ($2.15) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CBUS ($2.15) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CBUS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CBUS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.2x
Industry
-159.67x
Market
24.88x
CBUS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.8x
Industry
4.11x
CBUS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CBUS's financial health
Profit margin
Revenue
$1.2M
Net Income
-$23.1M
Profit Margin
-1,906.1%
CBUS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CBUS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$350.1M
Liabilities
$252.2M
Debt to equity
2.74
CBUS's short-term liabilities ($19.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CBUS's long-term liabilities ($232.36M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CBUS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CBUS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$14.0M
Investing
-$56.0k
Financing
-$306.0k
CBUS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CBUS vs Biotech Stocks
Cibus Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.